Medicine and Dentistry
Pediatrics
100%
General Anesthesia
56%
Airway Management
47%
Randomized Controlled Trial
45%
Obstructive Sleep Apnea
40%
Clinician
35%
Intubation
35%
Adverse Event
32%
Pediatrics Patient
31%
Neonates
28%
Bronchiolitis
28%
Hernia Surgery
28%
Inguinal Hernia
28%
Odds Ratio
26%
Emergency Department
26%
COVID-19
24%
Pediatric Anesthesia
24%
Anesthesiologist
23%
Primary Outcome
22%
Intensive Care
22%
Tonsillectomy
20%
Anesthesiology
20%
Tracheal Intubation
19%
Dexmedetomidine
19%
Sevoflurane
19%
Oral
19%
Diseases
18%
Health Care Cost
17%
Preoperative Care
16%
Difficult Airways
15%
Elective Surgery
14%
Oxygen Therapy
14%
Antiemetic
14%
Malignant Neoplasm
14%
Airway Device
13%
Induction of Anesthesia
13%
Adenotonsillectomy
13%
Respiratory Disease
13%
Perioperative Period
13%
Asthma
12%
Lung
12%
Medical Care
11%
Anaphylaxis
11%
Oximetry
11%
Chewing Gum
11%
Biological Marker
11%
Observational Study
11%
Bronchoscopy
10%
Attributable Risk
9%
Clinical Trial
9%
Medicine
9%
Preoperative Fasting
9%
Laryngoscopy
9%
Postoperative Vomiting
9%
Patient Positioning
9%
Retrospective Cohort Study
9%
Epidural Analgesia
9%
Appendectomy
9%
Masking
9%
Internal Anal Sphincter
9%
Constipation
9%
Spirometry
9%
Chronic Respiratory Tract Disease
9%
Clostridium Botulinum Type A
9%
Lactam
9%
Orthopantomogram
9%
Tooth Development
9%
Age Determination
9%
Remifentanil
9%
Low Drug Dose
9%
Health Literacy
9%
Cesarean Section
9%
Caudal Anesthesia
9%
Upper Respiratory Tract Infection
9%
Posterior Urethral Valve
9%
Bladder Dysfunction
9%
Promoter Region
9%
Nebulizer
9%
Tobramycin
9%
Hyperbaric Medicine
9%
Tracheostomy
9%
Electroencephalogram
9%
Burst Suppression
9%
Medical Procedures
9%
Postoperative Nausea and Vomiting
9%
Down Syndrome
9%
Airway Obstruction
9%
Pediatric Anesthesiology
9%
Optical Coherence Tomography
9%
Patient with Asthma
9%
Airway Smooth Muscle
9%
Abdominal Drainage
9%
Intestine Perforation
9%
Very Low Birth Weight
9%
Laparotomy
9%
Necrotizing Enterocolitis
9%
Systematic Review
9%
Neck Injury
9%
Inspiratory Capacity
9%
Respiratory Medicine
9%
Pharmacology, Toxicology and Pharmaceutical Science
Flucloxacillin
19%
Edaravone
19%
Microparticle
16%
Randomized Controlled Trial
15%
Asthma
14%
Antioxidant Capacity
12%
Tablet
11%
Eudragit
11%
Stingless Bee
11%
Base
10%
Nebulizer
10%
Tobramycin
10%
Motor Neuron Disease
10%
Polyelectrolyte
10%
Reverse Phase High Performance Liquid Chromatography
10%
SARS Coronavirus
9%
Appendicitis
9%
Constipation
9%
Drug Formulation
9%
Cohort Study
9%
Glycoside
9%
Eucalypt
9%
Phytochemical
9%
Natural Product
9%
Clover
9%
Peppermint
9%
Clostridium Botulinum Type A
9%
Lactam
9%
Subadult
9%
Electronic Cigarette
9%
Cefazolin
9%
Tolerability
9%
Flavonoid
9%
Pharmacokinetics
9%
Fibroblast Growth Factor 2
9%
Wound Healing
9%
Metered-Dose Inhaler
9%
Sleep Disordered Breathing
9%
Placebo
9%
Biological Marker
9%
Cytokine
9%
Postoperative Nausea and Vomiting
9%
Very Low Birth Weight
9%
Intestine Perforation
9%
Necrotizing Enterocolitis
9%
Cetomacrogol
9%
Fatty Acid
9%
Diclofenac
9%
Complexation
9%
Antioxidant
8%
Salbutamol
8%
Prednisolone
8%
Prednisolone Sodium Phosphate
8%
Zofran
7%
Subcutaneous Injection
7%
Palmitic Acid
6%
Hydrogen Peroxide
6%
Pandemic
5%
Immunoglobulin E
5%
Antiemetic Agent
5%
Ferrous Ion
5%
1,1 Diphenyl 2 Picrylhydrazyl
5%